Drug Shortage Report for SAPHNELO
| Report ID | 257190 |
| Drug Identification Number | 02522845 |
| Brand name | SAPHNELO |
| Common or Proper name | ANIFROLUMAB |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ANIFROLUMAB |
| Strength(s) | 150MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 mL |
| ATC code | L04AG |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-08-20 |
| Actual start date | |
| Estimated end date | 2025-12-31 |
| Actual end date | 2025-08-07 |
| Shortage status | Avoided shortage |
| Updated date | 2025-08-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected]. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-08-28 | English | Compare |
| v4 | 2025-08-07 | French | Compare |
| v3 | 2025-08-07 | English | Compare |
| v2 | 2025-08-07 | French | Compare |
| v1 | 2025-08-07 | English | Compare |
Showing 1 to 5 of 5